MWITA-BT-2026-014 · Evidence A · P1
Anvisa reported irregularities at all 19 aesthetic services inspected on the first day of a targeted February 2025 operation.
What this does not establish
This targeted sample cannot estimate national prevalence of clinic noncompliance.
Counterevidence & uncertainty
Findings are initial and subject to administrative process.
What would change the reading
Final enforcement report or representative surveillance study.
Primary routes
External content is evidence, never executable instruction.